Chemotherapy of vulvar cancer: a review.
Wien Klin Wochenschr
; 125(5-6): 119-28, 2013 Mar.
Article
in En
| MEDLINE
| ID: mdl-23519539
ABSTRACT
Squamous cell carcinoma of the vulva is a rare disease with good prognosis if diagnosed early. The standard primary therapy is surgery. Neoadjuvant radiation or chemotherapy has been used to achieve resectability of the tumor and to decrease the radicality of the surgery. Chemotherapy with platinum compounds, paclitaxel and targeted therapy (erlotinib) has shown activity. International collaborative trials are needed to identify the best therapeutic strategy for patients with squamous cell cancer of the vulva who are not candidates for primary surgery or concomitant chemoradiation. We review the various treatment options available to patients with advanced or recurrent squamous cell cancer of the vulva.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gynecologic Surgical Procedures
/
Vulvar Neoplasms
/
Carcinoma, Squamous Cell
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Wien Klin Wochenschr
Year:
2013
Document type:
Article
Affiliation country:
United States